DE69133402D1 - Protease von hepatitis-c-virus - Google Patents
Protease von hepatitis-c-virusInfo
- Publication number
- DE69133402D1 DE69133402D1 DE69133402T DE69133402T DE69133402D1 DE 69133402 D1 DE69133402 D1 DE 69133402D1 DE 69133402 T DE69133402 T DE 69133402T DE 69133402 T DE69133402 T DE 69133402T DE 69133402 D1 DE69133402 D1 DE 69133402D1
- Authority
- DE
- Germany
- Prior art keywords
- protease
- hepatitis
- virus
- proteases
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
- C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50543390A | 1990-04-04 | 1990-04-04 | |
US505433 | 1990-04-04 | ||
PCT/US1991/002210 WO1991015575A1 (en) | 1990-04-04 | 1991-04-04 | Hepatitis c virus protease |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69133402D1 true DE69133402D1 (de) | 2004-08-12 |
DE69133402T2 DE69133402T2 (de) | 2004-11-11 |
Family
ID=24010295
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69133617T Expired - Lifetime DE69133617D1 (de) | 1990-04-04 | 1991-04-04 | Protease von Hepatitis C Virus |
DE69133402T Expired - Lifetime DE69133402T2 (de) | 1990-04-04 | 1991-04-04 | Protease von hepatitis-c-virus |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69133617T Expired - Lifetime DE69133617D1 (de) | 1990-04-04 | 1991-04-04 | Protease von Hepatitis C Virus |
Country Status (12)
Country | Link |
---|---|
US (7) | US5371017A (de) |
EP (2) | EP1304335B1 (de) |
JP (3) | JP3320411B2 (de) |
AT (2) | ATE270326T1 (de) |
AU (1) | AU7675491A (de) |
CA (1) | CA2079105C (de) |
DE (2) | DE69133617D1 (de) |
DK (1) | DK0527788T3 (de) |
ES (2) | ES2324597T3 (de) |
IE (1) | IE911129A1 (de) |
PL (1) | PL169273B1 (de) |
WO (1) | WO1991015575A1 (de) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5371017A (en) * | 1990-04-04 | 1994-12-06 | Chiron Corporation | Hepatitis C virus protease |
US6194140B1 (en) | 1990-04-04 | 2001-02-27 | Chiron Corporation | HCV NS3 protein fragments having helicase activity and improved solubility |
EP1018558A3 (de) * | 1990-04-06 | 2002-06-05 | Genelabs Technologies, Inc. | Epitope des Virus von Hepatitis C |
JP3516681B2 (ja) | 1991-06-24 | 2004-04-05 | カイロン コーポレイション | C型肝炎ウイルス(hcv)ポリペプチド |
DE4428705A1 (de) * | 1994-08-12 | 1996-02-15 | Boehringer Mannheim Gmbh | Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus |
US5861267A (en) * | 1995-05-01 | 1999-01-19 | Vertex Pharmaceuticals Incorporated | Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity |
US5843752A (en) * | 1995-05-12 | 1998-12-01 | Schering Corporation | Soluble active hepatitis C virus protease |
US5767233A (en) * | 1995-05-12 | 1998-06-16 | Schering Corporation | Soluble cleavable substrates of the hepatitis C virus protease |
US5698396A (en) * | 1995-06-07 | 1997-12-16 | Ludwig Institute For Cancer Research | Method for identifying auto-immunoreactive substances from a subject |
IT1277914B1 (it) | 1995-08-22 | 1997-11-12 | Angeletti P Ist Richerche Bio | Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e |
US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US7235394B1 (en) | 1995-08-29 | 2007-06-26 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
EP0876512A1 (de) * | 1996-01-23 | 1998-11-11 | Viropharma Incorporated | Verfahren zur Identifizierung von RNA-Virus spezifischen Hemmstoffen |
US5766916A (en) * | 1996-04-24 | 1998-06-16 | Genelabs Technologies, Inc. | Hepatitis G virus protease |
US5990276A (en) * | 1996-05-10 | 1999-11-23 | Schering Corporation | Synthetic inhibitors of hepatitis C virus NS3 protease |
US5861297A (en) * | 1996-09-27 | 1999-01-19 | Merck & Co., Inc. | Detergent-free hepatitis C protease |
AU4904397A (en) * | 1996-10-17 | 1998-05-11 | Chiron Corporation | Protease regulator screening assay |
US7049428B1 (en) * | 1998-03-04 | 2006-05-23 | Washington University | HCV variants |
US7338759B1 (en) | 1997-03-04 | 2008-03-04 | Washington University | HCV variants |
US5849800A (en) * | 1997-03-28 | 1998-12-15 | The Penn State Research Foundation | Use of amantadine for treatment of Hepatitis C |
US20020034732A1 (en) * | 1997-07-30 | 2002-03-21 | Daniel J. Capon | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
IL137458A0 (en) * | 1998-01-30 | 2001-07-24 | Gen Hospital Corp | Genetic immunization with nonstructural proteins of hepatitis c virus |
US7078500B1 (en) * | 1998-01-30 | 2006-07-18 | The General Hospital Corporation | Genetic immunization with nonstructural proteins of hepatitis C virus |
JP2002510509A (ja) * | 1998-04-02 | 2002-04-09 | バイロファーマ・インコーポレイテッド | C型肝炎ウイルスns5b組成物およびその使用方法 |
CA2658218C (en) | 1998-04-17 | 2014-10-28 | Innogenetics N.V. | Improved immunodiagnostic assays using reducing agents |
US6280940B1 (en) | 1998-08-05 | 2001-08-28 | Agouron Pharmaceuticals, Inc. | Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease |
AU2217800A (en) * | 1998-12-24 | 2000-07-31 | Small Molecule Therapeutics, Inc. | Methods and compositions for identifying protease modulators |
WO2000040707A1 (en) | 1999-01-08 | 2000-07-13 | Bristol-Myers Squibb Co. | Modified forms of hepatitis c virus ns3 protease |
WO2000075338A2 (en) * | 1999-06-04 | 2000-12-14 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF |
US7084266B1 (en) | 1999-06-04 | 2006-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof |
WO2001035316A2 (en) * | 1999-11-10 | 2001-05-17 | Structural Bioinformatics, Inc. | Computationally derived protein structures in pharmacogenomics |
US20060141480A1 (en) * | 1999-11-10 | 2006-06-29 | Kalyanaraman Ramnarayan | Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics and clinical applications |
US6986892B1 (en) * | 1999-11-24 | 2006-01-17 | Chiron Corporation | Immunogenic Hepatitis C virus non-structural polypeptides |
US20050074465A1 (en) * | 1999-11-24 | 2005-04-07 | Michael Houghton | HCV fusion proteins with modified NS3 domains |
ES2317900T3 (es) | 2000-04-05 | 2009-05-01 | Schering Corporation | Inhibidores de serina proteasa ns3 macrociclicos del virus de la hepatitis c que comprenden fragmentos n-ciclicas p2. |
NZ521456A (en) | 2000-04-19 | 2004-07-30 | Schering Corp | Macrocyclic NS3-Serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
EP1160332A1 (de) * | 2000-05-30 | 2001-12-05 | Amsterdam Support Diagnostics B.V. | Verfahren zum Nachweis von enzymatischer Aktivität oder von Resistenz gegen enzymatiche Inhibitoren |
US7491808B2 (en) * | 2000-06-15 | 2009-02-17 | Novartis Vaccines And Diagnostics, Inc. | HCV non-structural protein mutants and uses thereof |
AU8063701A (en) * | 2000-07-21 | 2002-02-05 | Schering Corp | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
US7012066B2 (en) * | 2000-07-21 | 2006-03-14 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
WO2002008251A2 (en) * | 2000-07-21 | 2002-01-31 | Corvas International, Inc. | Peptides as ns3-serine protease inhibitors of hepatitis c virus |
US7244721B2 (en) * | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
AR029851A1 (es) | 2000-07-21 | 2003-07-16 | Dendreon Corp | Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c |
US6680059B2 (en) | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
US7022830B2 (en) | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
CA2419418A1 (en) * | 2000-08-17 | 2002-02-21 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
US6858590B2 (en) * | 2000-08-17 | 2005-02-22 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
HUP0303436A2 (hu) | 2000-12-12 | 2004-01-28 | Schering Corp. | Diaril-peptidek mint a hepatitis C vírus NS3-szerin proteáz inhibitorai, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
EP1435974A4 (de) * | 2001-09-28 | 2006-09-06 | Idenix Cayman Ltd | Verfahren und zusamemnsetzungen zur behandlung des hepatitis-c-virus mit 4'-modifizierten nucleosiden |
WO2003062228A1 (en) * | 2002-01-23 | 2003-07-31 | Schering Corporation | Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
CA2481502A1 (en) * | 2002-04-04 | 2003-10-16 | Achillion Pharmaceuticals, Inc. | Hcv antiviral and cytotoxicity drug screening assay |
US7666627B2 (en) * | 2002-08-08 | 2010-02-23 | Targetex Kft. | Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof |
US7439042B2 (en) * | 2002-12-16 | 2008-10-21 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
CA2527907A1 (en) * | 2003-06-03 | 2004-12-09 | Benitec Australia Limited | Double-stranded hairpin rnas for rnai |
WO2005017125A2 (en) * | 2003-08-14 | 2005-02-24 | California Institute Of Molecular Medicine | Method for isolation and replication of infectious human hepatitis-c virus |
US7449447B2 (en) * | 2003-08-26 | 2008-11-11 | Schering Corporation | Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus |
BRPI0414814A (pt) | 2003-09-26 | 2006-11-14 | Schering Corp | inibidores macrocìclicos de protease de serina ns3 de vìrus de hepatite c |
US20110150835A1 (en) * | 2003-09-26 | 2011-06-23 | Schering Corporation | Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease |
US7253160B2 (en) * | 2003-11-20 | 2007-08-07 | Schering Corporation | Depeptidized inhibitors of hepatitis C virus NS3 protease |
ATE438622T1 (de) | 2004-02-27 | 2009-08-15 | Schering Corp | 3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus |
PL1730110T3 (pl) * | 2004-02-27 | 2010-11-30 | Merck Sharp & Dohme | Siarkowe związki jako inhibitory proteazy serynowej NS3 wirusa zapalenia wątroby typu C |
US7816326B2 (en) * | 2004-02-27 | 2010-10-19 | Schering Corporation | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
EP1939213B1 (de) * | 2004-02-27 | 2010-08-25 | Schering Corporation | Neuartige Verbindungen als Hemmer von Hepatitis C-Virus NS3-Serinprotease |
TW200602037A (en) * | 2004-02-27 | 2006-01-16 | Schering Corp | Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
KR20060124725A (ko) * | 2004-02-27 | 2006-12-05 | 쉐링 코포레이션 | C형 간염 바이러스 ns3 프로테아제의 억제제 |
CN103060324B (zh) | 2004-03-05 | 2015-04-01 | 贝尼泰克生物制药有限公司 | 用于RNAi试剂同时递送的多启动子表达盒 |
AR049635A1 (es) * | 2004-05-06 | 2006-08-23 | Schering Corp | (1r,2s,5s)-n-((1s)-3-amino-1-(ciclobutilmetil)-2,3-dioxopropil)-3-((2s)-2-((((1,1-dimetiletil)amino)carbonil)amino)-3,3-dimetil-1-oxobutil)-6,6-dimetil-3-azabiciclo(3.1.0)hexan-2-carboxamida como inhibidor de la ns3/ns4a serina proteasa del virus de la hepatitis c |
EP1773868B1 (de) | 2004-05-20 | 2009-07-15 | Schering Corporation | Substituierte proline als hemmer der ns3-serinprotease des hepatits-c-virus |
ATE513844T1 (de) * | 2004-08-27 | 2011-07-15 | Schering Corp | Acylsulfonamidverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus |
MX2007004662A (es) * | 2004-10-18 | 2007-11-23 | Globeimmune Inc | Terapia basada en levaduras para infeccion cronica por hepatitis c. |
WO2006121468A1 (en) * | 2004-11-22 | 2006-11-16 | Genelabs Technologies, Inc. | 5-nitro-nucleoside compounds for treating viral infections |
EP1853618A1 (de) * | 2005-02-28 | 2007-11-14 | Genelabs Technologies, Inc. | Tricyclische nukleosidverbindungen zur behandlung viraler infektionen |
WO2006116557A1 (en) * | 2005-04-25 | 2006-11-02 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
WO2007031867A2 (en) * | 2005-05-25 | 2007-03-22 | Tripep Ab | A hepatitis c virus non-stru tural ns3/4a fusion gene |
US20070237818A1 (en) * | 2005-06-02 | 2007-10-11 | Malcolm Bruce A | Controlled-release formulation of HCV protease inhibitor and methods using the same |
KR20080021634A (ko) * | 2005-06-02 | 2008-03-07 | 쉐링 코포레이션 | 약제학적 조성물 및 이를 사용한 치료 방법 |
PL1891089T3 (pl) | 2005-06-02 | 2015-05-29 | Merck Sharp & Dohme | Inhibitory proteazy HCV w połączeniu z pokarmem |
BRPI0612124A2 (pt) * | 2005-06-24 | 2010-10-19 | Genelabs Tech Inc | derivados de heteroarila para o tratamento de viroses |
EP1981523A2 (de) * | 2006-02-09 | 2008-10-22 | Schering Corporation | Neuartige hcv-inhibitor-kombinationen und entsprechende verfahren |
MX2008011354A (es) * | 2006-03-03 | 2008-09-15 | Schering Corp | Combinaciones farmaceuticas de inhibidores de proteasa del virus de hepatitis c y del sitio interno de entrada ribosomal del virus de hepatitis c. |
JP2009530382A (ja) * | 2006-03-23 | 2009-08-27 | シェーリング コーポレイション | Hcvプロテアーゼインヒビターとcyp3a4インヒビターとの組み合わせ、および関連する処置方法 |
MX2008013119A (es) | 2006-04-11 | 2008-10-21 | Novartis Ag | Inhibidores de hcv/vih y sus usos. |
TW200817413A (en) * | 2006-07-20 | 2008-04-16 | Genelabs Tech Inc | Polycyclic viral inhibitors |
US8071561B2 (en) | 2007-08-16 | 2011-12-06 | Chrontech Pharma Ab | Immunogen platform |
WO2009029729A1 (en) * | 2007-08-31 | 2009-03-05 | Genelabs Technologies, Inc. | Amino tricyclic-nucleoside compounds, compositions, and methods of use |
CA2703954A1 (en) * | 2007-10-30 | 2009-05-07 | Intermune, Inc. | Hcv genotyping and phenotyping |
US8309685B2 (en) | 2007-12-21 | 2012-11-13 | Celgene Avilomics Research, Inc. | HCV protease inhibitors and uses thereof |
US8293705B2 (en) | 2007-12-21 | 2012-10-23 | Avila Therapeutics, Inc. | HCV protease inhibitors and uses thereof |
CN101951770B (zh) * | 2007-12-21 | 2014-12-31 | 阿维拉制药公司 | Hcv蛋白酶抑制剂和其用途 |
KR20150113217A (ko) * | 2007-12-21 | 2015-10-07 | 셀진 아빌로믹스 리서치, 인코포레이티드 | Hcv 프로테아제 억제제 및 이의 용도 |
US7699111B2 (en) * | 2008-01-29 | 2010-04-20 | Tam International, Inc. | Float collar and method |
WO2009130588A2 (en) * | 2008-04-22 | 2009-10-29 | Tripep Ab | Immunogen platform |
CN102131813B (zh) | 2008-06-24 | 2014-07-30 | 科德克希思公司 | 用于制备基本上立体异构纯的稠合二环脯氨酸化合物的生物催化方法 |
US8188137B2 (en) | 2008-08-15 | 2012-05-29 | Avila Therapeutics, Inc. | HCV protease inhibitors and uses thereof |
EP2331125A4 (de) | 2008-09-19 | 2013-03-27 | Globeimmune Inc | Immuntherapie zur für chronische hepatitis-c-virus-infektionen |
TW201032801A (en) | 2008-12-12 | 2010-09-16 | Schering Corp | Deuterated compounds as hepatitis C virus (HCV) inhibitors |
US20110027229A1 (en) | 2009-07-31 | 2011-02-03 | Medtronic, Inc. | Continuous subcutaneous administration of interferon-alpha to hepatitis c infected patients |
AR082453A1 (es) | 2010-04-21 | 2012-12-12 | Novartis Ag | Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos |
CA2806108A1 (en) | 2010-07-22 | 2012-01-26 | Novartis Ag | 2,3,5-trisubstituted thiophene compounds and uses thereof |
EP2658857B1 (de) | 2010-12-29 | 2016-11-02 | Inhibitex, Inc. | Substituierte purin-nukleoside, phosphoroamidate und phosphorodiamidatderivate zur behandlung von virusinfektionen |
KR101784455B1 (ko) | 2015-12-04 | 2017-10-11 | 주식회사 바이오노트 | C형 간염 바이러스의 친수성 단편을 포함하는 융합 폴리펩티드, 그를 포함하는 c형 간염 바이러스 감염을 진단하기 위한 조성물, 키트, 및 방법 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4702909A (en) * | 1982-05-05 | 1987-10-27 | Louisiana State University A & M | Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent |
US4870026A (en) * | 1982-09-16 | 1989-09-26 | The General Hospital Corporation | Non-A, non-B. hepatitis, virus, methods of identification purification, characterization, diagnosis and immunization |
CA1293591C (en) * | 1985-01-11 | 1991-12-24 | Charles A. Kettner | Peptide substrates for detecting virus-specified protease activity |
US4673634A (en) * | 1985-03-08 | 1987-06-16 | The United States Of America As Represented By The Department Of Health And Human Services | Purified antigen from non-A, non-B hepatitis causing factor |
US5523215A (en) * | 1985-03-28 | 1996-06-04 | Chiron Corporation | Enhanced purification and expression of insoluble recombinant proteins |
US5218099A (en) * | 1986-04-01 | 1993-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Post-transfusion, non-A, non-B hepatitis virus polynucleotides |
US5350671A (en) * | 1987-11-18 | 1994-09-27 | Chiron Corporation | HCV immunoassays employing C domain antigens |
CN1074422C (zh) * | 1987-11-18 | 2001-11-07 | 希龙股份有限公司 | 制备含有hcv表位的分离多肽的方法 |
US5010175A (en) * | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
US5176994A (en) * | 1988-12-21 | 1993-01-05 | Immuno Japan Inc. | Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein |
HU225068B1 (en) * | 1989-03-17 | 2006-05-29 | Chiron Corp | Process for producing diagnostics and vaccine of nanbh |
CA2065287C (en) | 1989-09-15 | 1999-12-21 | Tatsuo Miyamura | New hcv isolates |
US5372928A (en) * | 1989-09-15 | 1994-12-13 | Chiron Corporation | Hepatitis C virus isolates |
US5371017A (en) * | 1990-04-04 | 1994-12-06 | Chiron Corporation | Hepatitis C virus protease |
US5258496A (en) * | 1990-07-10 | 1993-11-02 | Scios Nova Inc. | Isolation and purification of lung surfactant protein |
CA2090407A1 (en) | 1990-09-21 | 1992-03-22 | Ronald M. Evans | Functional antagonism between proto-oncoprotein c-jun and hormone receptors |
-
1991
- 1991-04-04 US US07/680,296 patent/US5371017A/en not_active Expired - Lifetime
- 1991-04-04 IE IE112991A patent/IE911129A1/en not_active IP Right Cessation
- 1991-04-04 ES ES02019415T patent/ES2324597T3/es not_active Expired - Lifetime
- 1991-04-04 ES ES91908105T patent/ES2219637T3/es not_active Expired - Lifetime
- 1991-04-04 DE DE69133617T patent/DE69133617D1/de not_active Expired - Lifetime
- 1991-04-04 DE DE69133402T patent/DE69133402T2/de not_active Expired - Lifetime
- 1991-04-04 AT AT91908105T patent/ATE270326T1/de not_active IP Right Cessation
- 1991-04-04 EP EP02019415A patent/EP1304335B1/de not_active Expired - Lifetime
- 1991-04-04 CA CA002079105A patent/CA2079105C/en not_active Expired - Lifetime
- 1991-04-04 JP JP50763191A patent/JP3320411B2/ja not_active Expired - Lifetime
- 1991-04-04 DK DK91908105T patent/DK0527788T3/da active
- 1991-04-04 PL PL91296328A patent/PL169273B1/pl unknown
- 1991-04-04 WO PCT/US1991/002210 patent/WO1991015575A1/en active IP Right Grant
- 1991-04-04 AU AU76754/91A patent/AU7675491A/en not_active Abandoned
- 1991-04-04 EP EP91908105A patent/EP0527788B1/de not_active Expired - Lifetime
- 1991-04-04 AT AT02019415T patent/ATE433460T1/de not_active IP Right Cessation
-
1994
- 1994-12-06 US US08350884 patent/US5585258C1/en not_active Expired - Lifetime
-
1995
- 1995-05-12 US US08440548 patent/US5597691C1/en not_active Expired - Lifetime
-
1996
- 1996-09-06 US US08/709,173 patent/US5712145A/en not_active Expired - Lifetime
- 1996-09-06 US US08/709,177 patent/US5885799A/en not_active Expired - Lifetime
-
2001
- 2001-06-11 JP JP2001176369A patent/JP3507045B2/ja not_active Expired - Lifetime
- 2001-06-18 US US09/884,456 patent/US20030027317A1/en not_active Abandoned
- 2001-06-18 US US09/884,455 patent/US20030064499A1/en not_active Abandoned
-
2003
- 2003-10-31 JP JP2003373722A patent/JP2004073212A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JPH05507612A (ja) | 1993-11-04 |
DK0527788T3 (da) | 2004-09-06 |
EP0527788B1 (de) | 2004-06-30 |
EP1304335A3 (de) | 2004-04-07 |
ATE433460T1 (de) | 2009-06-15 |
ES2324597T3 (es) | 2009-08-11 |
EP0527788A1 (de) | 1993-02-24 |
IE20060594A1 (en) | 2009-05-27 |
EP1304335B1 (de) | 2009-06-10 |
IE911129A1 (en) | 1991-10-09 |
US5585258C1 (en) | 2002-01-15 |
ES2219637T3 (es) | 2004-12-01 |
EP1304335A2 (de) | 2003-04-23 |
CA2079105C (en) | 2000-06-13 |
US5585258A (en) | 1996-12-17 |
DE69133617D1 (de) | 2009-07-23 |
US5597691A (en) | 1997-01-28 |
JP3507045B2 (ja) | 2004-03-15 |
ATE270326T1 (de) | 2004-07-15 |
CA2079105A1 (en) | 1991-10-05 |
DE69133402T2 (de) | 2004-11-11 |
PL169273B1 (pl) | 1996-06-28 |
JP2002051791A (ja) | 2002-02-19 |
AU7675491A (en) | 1991-10-30 |
WO1991015575A1 (en) | 1991-10-17 |
US20030064499A1 (en) | 2003-04-03 |
US5712145A (en) | 1998-01-27 |
JP3320411B2 (ja) | 2002-09-03 |
US5597691C1 (en) | 2001-12-11 |
US5885799A (en) | 1999-03-23 |
JP2004073212A (ja) | 2004-03-11 |
US5371017A (en) | 1994-12-06 |
US20030027317A1 (en) | 2003-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5597691C1 (en) | Hepatitus c virus protease | |
DE69709671D1 (de) | Inhibitoren von serinproteasen, insbesondere von ns3-protease des hepatitis-c-virus | |
ATE229543T1 (de) | Polypeptide des hepatitis c-virus (hiv) | |
DE69839557D1 (de) | Klonierte genome von infektiösen hepatitis c viren und deren verwendungen | |
DE68903165D1 (de) | Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein. | |
DE3885431D1 (de) | Expression der viral kodierten Protease P2A des HRV2. | |
DK0698216T3 (da) | Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser | |
ES2175462T3 (es) | Composiciones cristalizables que comprenden un complejo del dominio de proteasa ns3 del virus de la hepatitis c/ns4a, y cristales asi obtenidos. | |
SI0932617T1 (en) | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease | |
DE60034884D1 (de) | Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen | |
FI923020A (fi) | Inte a inte b-sekvenser. | |
DE69125066D1 (de) | cDNS-Sequenz und Detektion des Hepatitis C-Virus | |
IT1270941B (it) | Peptidi di hcv e loro usi. | |
ATE96839T1 (de) | Expression der viral kodierten protease p2a des hrv2. | |
Arocha-Pi | Studies on the degradation of fibrinogen by proteolytic enzymes from the larvae of Lanomia achelous (Cramer) | |
FI981381A (fi) | Menetelmä HCV-polypeptidien valmistamiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US |